<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34989063</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>12</Day></DateCompleted><DateRevised><Year>2022</Year><Month>06</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1468-1331</ISSN><JournalIssue CitedMedium="Internet"><Volume>29</Volume><Issue>5</Issue><PubDate><Year>2022</Year><Month>May</Month></PubDate></JournalIssue><Title>European journal of neurology</Title><ISOAbbreviation>Eur J Neurol</ISOAbbreviation></Journal><ArticleTitle>Upper motor neuron dysfunction is associated with the presence of behavioural impairment in patients with amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>1402</StartPage><EndPage>1409</EndPage><MedlinePgn>1402-1409</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/ene.15243</ELocationID><Abstract><AbstractText Label="BACKGROUND AND PURPOSE">Increasing evidence shows that approximately half of patients with amyotrophic lateral sclerosis (ALS) display cognitive (ALSci) or behavioural (ALSbi) impairment, or both (ALScbi). The aim of our study was to assess whether the burden of upper and lower motor neuron involvement is associated with the presence of cognitive and behavioural impairment.</AbstractText><AbstractText Label="METHODS">A single-centre retrospective cohort of 110 Italian ALS patients was evaluated to assess correlations between motor and cognitive/behavioural phenotypes. Upper motor neuron regional involvement was measured with the Penn Upper Motor Neuron Score (PUMNS), whilst lower motor neuron signs were assessed using the Lower Motor Neuron Score. The Edinburgh Cognitive and Behavioural ALS Screen-Italian version and the Frontal Behaviour Inventory were administered to evaluate patients' cognitive and behavioural profiles.</AbstractText><AbstractText Label="RESULTS">The PUMNS at first visit was significantly higher in behaviourally impaired ALS patients (ALSbi and ALScbi) compared to behaviourally unimpaired individuals (ALS and ALSci) (9.9 vs. 6.9, p&#xa0;=&#xa0;0.014). Concerning the different Frontal Behaviour Inventory subdomains, higher PUMNS correlated with the presence of apathy, emotive indifference, inflexibility, inattention, perseveration and aggressiveness.</AbstractText><AbstractText Label="CONCLUSION">To our knowledge, this is the first study showing that a clinical prominent upper motor neuron dysfunction is associated with a more significant behavioural impairment in ALS patients, suggesting the hypothesis of a preferential spreading of the pathology from the motor cortex to the ventromedial prefrontal and orbitofrontal cortex in this group of patients.</AbstractText><CopyrightInformation>&#xa9; 2022 European Academy of Neurology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Maranzano</LastName><ForeName>Alessio</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-3642-9584</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Istituto Auxologico Italiano IRCCS, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathophysiology and Transplantation, 'Dino Ferrari' Center, Universit&#xe0; degli Studi di Milano, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Poletti</LastName><ForeName>Barbara</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0003-4398-2051</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Istituto Auxologico Italiano IRCCS, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Solca</LastName><ForeName>Federica</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Pathophysiology and Transplantation, 'Dino Ferrari' Center, Universit&#xe0; degli Studi di Milano, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Torre</LastName><ForeName>Silvia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology, Istituto Auxologico Italiano IRCCS, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Colombo</LastName><ForeName>Eleonora</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Neurology, Istituto Auxologico Italiano IRCCS, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathophysiology and Transplantation, 'Dino Ferrari' Center, Universit&#xe0; degli Studi di Milano, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Far&#xe9;</LastName><ForeName>Matteo</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-8956-7406</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Ospedale San Gerardo ASST, Monza, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferrucci</LastName><ForeName>Roberta</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0001-5109-9483</Identifier><AffiliationInfo><Affiliation>'Aldo Ravelli' Center for Neurotechnology and Experimental Brain Therapeutics, Department of Health Sciences, International Medical School, Universit&#xe0; Degli Studi di Milano, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>ASST Santi Paolo e Carlo, Neurology Clinic III, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carelli</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Neurology, Istituto Auxologico Italiano IRCCS, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Verde</LastName><ForeName>Federico</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-3977-6995</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Istituto Auxologico Italiano IRCCS, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathophysiology and Transplantation, 'Dino Ferrari' Center, Universit&#xe0; degli Studi di Milano, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morelli</LastName><ForeName>Claudia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Neurology, Istituto Auxologico Italiano IRCCS, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Silani</LastName><ForeName>Vincenzo</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0002-7698-3854</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Istituto Auxologico Italiano IRCCS, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathophysiology and Transplantation, 'Dino Ferrari' Center, Universit&#xe0; degli Studi di Milano, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ticozzi</LastName><ForeName>Nicola</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0001-5963-7426</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Istituto Auxologico Italiano IRCCS, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathophysiology and Transplantation, 'Dino Ferrari' Center, Universit&#xe0; degli Studi di Milano, Milan, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>01</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur J Neurol</MedlineTA><NlmUniqueID>9506311</NlmUniqueID><ISSNLinking>1351-5101</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003071" MajorTopicYN="N">Cognition</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009483" MajorTopicYN="N">Neuropsychological Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ECAS</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">behavioural impairment</Keyword><Keyword MajorTopicYN="N">motor phenotype, upper motor neuron</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>12</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>6</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>12</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>1</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>1</Month><Day>6</Day><Hour>6</Hour><Minute>28</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34989063</ArticleId><ArticleId IdType="doi">10.1111/ene.15243</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>van Es MA, Hardiman O, Chio A, et al. Amyotrophic lateral sclerosis. Lancet. 2017;390(10107):2084-2098. 10.1016/S0140-6736(17)31287-4. Epub 2017 May 25 PMID: 28552366.</Citation></Reference><Reference><Citation>Burrell JR, Halliday GM, Kril JJ, et al. The frontotemporal dementia-motor neuron disease continuum. Lancet. 2016;388(10047):919-931. 10.1016/S0140-6736(16)00737-6. Epub 2016 Mar 14 PMID: 26987909.</Citation></Reference><Reference><Citation>Chi&#xf2; A, Moglia C, Canosa A, et al. Cognitive impairment across ALS clinical stages in a population-based cohort. Neurology. 2019;93(10):e984-e994. 10.1212/WNL.0000000000008063. Epub 2019 Aug 13. PMID: 31409738; PMCID: PMC6745732.</Citation></Reference><Reference><Citation>Rippon GA, Scarmeas N, Gordon PH, et al. An observational study of cognitive impairment in amyotrophic lateral sclerosis. Arch Neurol. 2006;63(3):345-352. 10.1001/archneur.63.3.345. PMID: 16533961.</Citation></Reference><Reference><Citation>Benbrika S, Desgranges B, Eustache F, Viader F. Cognitive, emotional and psychological manifestations in amyotrophic lateral sclerosis at baseline and overtime: a review. Front Neurosci. 2019;13:951. 10.3389/fnins.2019.00951. PMID: 31551700; PMCID: PMC6746914.</Citation></Reference><Reference><Citation>Strong MJ, Abrahams S, Goldstein LH, et al. Amyotrophic lateral sclerosis-frontotemporal spectrum disorder (ALS-FTSD): revised diagnostic criteria. Amyotroph Lateral Scler Frontotemporal Degener. 2017;18(3-4):153-174. 10.1080/21678421.2016.1267768. Epub 2017 Jan 5. PMID: 28054827; PMCID: PMC7409990.</Citation></Reference><Reference><Citation>Abrahams S, Newton J, Niven E, Foley J, Bak TH. Screening for cognition and behaviour changes in ALS. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15(1-2):9-14. 10.3109/21678421.2013.805784. Epub 2013 Jun 19 PMID: 23781974.</Citation></Reference><Reference><Citation>Gosselt IK, Nijboer TCW, Van Es MA. An overview of screening instruments for cognition and behavior in patients with ALS: selecting the appropriate tool for clinical practice. Amyotroph Lateral Scler Frontotemporal Degener. 2020;21(5-6):324-336. 10.1080/21678421.2020.1732424. Epub 2020 Mar 11 PMID: 32157912.</Citation></Reference><Reference><Citation>Poletti B, Solca F, Carelli L, et al. The validation of the Italian Edinburgh Cognitive and Behavioural ALS Screen (ECAS). Amyotroph Lateral Scler Frontotemporal Degener. 2016;17(7-8):489-498. 10.1080/21678421.2016.1183679. Epub 2016 May 24 PMID: 27219526.</Citation></Reference><Reference><Citation>Simon N, Goldstein LH. Screening for cognitive and behavioral change in amyotrophic lateral sclerosis/motor neuron disease: a systematic review of validated screening methods. Amyotroph Lateral Scler Frontotemporal Degener. 2019;20(1-2):1-11. 10.1080/21678421.2018.1530264. Epub 2018 Dec 26 PMID: 30585510.</Citation></Reference><Reference><Citation>Rascovsky K, Hodges JR, Knopman D, et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain. 2011;134(Pt 9):2456-2477. 10.1093/brain/awr179. Epub 2011 Aug 2. PMID: 21810890; PMCID: PMC3170532.7</Citation></Reference><Reference><Citation>Elamin M, Bede P, Byrne S, et al. Cognitive changes predict functional decline in ALS: a population-based longitudinal study. Neurology. 2013;80(17):1590-1597. 10.1212/WNL.0b013e31828f18ac. Epub 2013 Apr 3 PMID: 23553481.</Citation></Reference><Reference><Citation>Bock M, Duong YN, Kim A, Allen I, Murphy J, Lomen-Hoerth C. Progression and effect of cognitive-behavioral changes in patients with amyotrophic lateral sclerosis. Neurol Clin Pract. 2017;7(6):488-498. 10.1212/CPJ.0000000000000397. PMID: 29431172; PMCID: PMC5800712.</Citation></Reference><Reference><Citation>Higashihara M, Pavey N, van den Bos M, Menon P, Kiernan MC, Vucic S. Association of cortical hyperexcitability and cognitive impairment in patients with amyotrophic lateral sclerosis. Neurology. 2021;96(16):e2090-e2097. 10.1212/WNL.0000000000011798</Citation></Reference><Reference><Citation>Crockford C, Newton J, Lonergan K, et al. ALS-specific cognitive and behavior changes associated with advancing disease stage in ALS. Neurology. 2018;91(15):e1370-e1380. 10.1212/WNL.0000000000006317. Epub 2018 Sep 12. PMID: 30209236; PMCID: PMC6177274.</Citation></Reference><Reference><Citation>Braak H, Brettschneider J, Ludolph AC, et al. Amyotrophic lateral sclerosis-a model of corticofugal axonal spread. Nat Rev Neurol. 2013;9(12):708-714. 10.1038/nrneurol.2013.221. Epub 2013 Nov 12. PMID: 24217521; PMCID: PMC3943211.</Citation></Reference><Reference><Citation>Brettschneider J, Del Tredici K, Irwin DJ, et al. Sequential distribution of pTDP-43 pathology in behavioral variant frontotemporal dementia (bvFTD). Acta Neuropathol. 2014;127(3):423-439. 10.1007/s00401-013-1238-y. Epub 2014 Jan 10.</Citation></Reference><Reference><Citation>Brooks BR, Miller RG, Swash M, Munsat TL, World Federation of Neurology Research Group on Motor Neuron Diseases. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1(5):293-299. 10.1080/146608200300079536. PMID: 11464847.</Citation></Reference><Reference><Citation>Quinn C, Edmundson C, Dahodwala N, Elman L. Reliable and efficient scale to assess upper motor neuron disease burden in amyotrophic lateral sclerosis. Muscle Nerve. 2020;61(4):508-511. 10.1002/mus.26764. Epub 2019 Dec 20 PMID: 31743477.</Citation></Reference><Reference><Citation>Devine MS, Ballard E, O&#x2019;Rourke P, Kiernan MC, Mccombe PA, Henderson RD. Targeted assessment of lower motor neuron burden is associated with survival in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2016;17(3-4):184-190. 10.3109/21678421.2015.1125502. Epub 2015 Dec 24 PMID: 26700804.</Citation></Reference><Reference><Citation>Alberici A, Geroldi C, Cotelli M, et al. The Frontal Behavioural Inventory (Italian version) differentiates frontotemporal lobar degeneration variants from Alzheimer's disease. Neurol Sci. 2007;28(2):80-86. 10.1007/s10072-007-0791-3. PMID: 17464470.</Citation></Reference><Reference><Citation>Govaarts R, Beeldman E, Kampelmacher MJ, et al. The frontotemporal syndrome of ALS is associated with poor survival. J Neurol. 2016;263(12):2476-2483. 10.1007/s00415-016-8290-1. Epub 2016 Sep 26. PMID: 27671483; PMCID: PMC5110703.</Citation></Reference><Reference><Citation>Nguyen C, Caga J, Mahoney CJ, Kiernan MC, Huynh W. Behavioural changes predict poorer survival in amyotrophic lateral sclerosis. Brain Cogn. 2021;150:105710. 10.1016/j.bandc.2021.105710. PMID: 33725515.</Citation></Reference><Reference><Citation>Hu WT, Shelnutt M, Wilson A, et al. Behavior matters-cognitive predictors of survival in amyotrophic lateral sclerosis. PLoS One. 2013;8(2):e57584. 10.1371/journal.pone.0057584. Epub 2013 Feb 27. PMID: 23460879; PMCID: PMC3583832.</Citation></Reference><Reference><Citation>Olney RK, Murphy J, Forshew D, et al. The effects of executive and behavioral dysfunction on the course of ALS. Neurology. 2005;65(11):1774-1777. 10.1212/01.wnl.0000188759.87240.8b. PMID: 16344521.</Citation></Reference><Reference><Citation>Gregory JM, Dade K, Bak TH, et al. Gregory JM, McDade K, Bak TH, Pal S, Chandran S, Smith C, Abrahams S. Executive, language and fluency dysfunction are markers of localised TDP-43 cerebral pathology in non-demented ALS. J Neurol Neurosurg Psychiatry. 2020;91(2):149-157. 10.1136/jnnp-2019-320807. Epub 2019 Sep 12. PMID: 31515300; PMCID: PMC6996101.</Citation></Reference><Reference><Citation>Manera U, Peotta L, Iazzolino B, et al. The characteristics of cognitive impairment in ALS patients depend on the lateralization of motor damage. Brain Sci. 2020;10(9):650. 10.3390/brainsci10090650. PMID: 32961718; PMCID: PMC7563934.</Citation></Reference><Reference><Citation>Coricelli G. Two-levels of mental states attribution: from automaticity to voluntariness. Neuropsychologia. 2005;43(2):294-300. 10.1016/j.neuropsychologia.2004.11.015. Epub 2004 Dec 30 PMID: 15707913.</Citation></Reference><Reference><Citation>Brothers L, Ring B. A neuroethological framework for the representation of minds. J Cogn Neurosci. 1992;4(2):107-118. 10.1162/jocn.1992.4.2.107. PMID: 23967887.</Citation></Reference><Reference><Citation>Shamay-Tsoory SG, Tomer R, Goldsher D, Berger BD, Aharon-Peretz J. Impairment in cognitive and affective empathy in patients with brain lesions: anatomical and cognitive correlates. J Clin Exp Neuropsychol. 2004;26(8):1113-1127. 10.1080/13803390490515531. PMID: 15590464.</Citation></Reference><Reference><Citation>Abu-Akel A, Shamay-Tsoory S. Neuroanatomical and neurochemical bases of theory of mind. Neuropsychologia. 2011;49(11):2971-2984. 10.1016/j.neuropsychologia.2011.07.012. Epub 2011 Jul 23 PMID: 21803062.</Citation></Reference><Reference><Citation>Poletti M, Enrici I, Adenzato M. Cognitive and affective theory of mind in neurodegenerative diseases: neuropsychological, neuroanatomical and neurochemical levels. Neurosci Biobehav Rev. 2012;36(9):2147-2164. 10.1016/j.neubiorev.2012.07.004. Epub 2012 Jul 20 PMID: 22819986.</Citation></Reference><Reference><Citation>van der Hulst EJ, Bak TH, Abrahams S. Impaired affective and cognitive theory of mind and behavioural change in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2015;86(11):1208-1215. 10.1136/jnnp-2014-309290. Epub 2014 Dec 4 PMID: 25476003.</Citation></Reference><Reference><Citation>Lul&#xe9; D, B&#xf6;hm S, M&#xfc;ller HP, et al. Cognitive phenotypes of sequential staging in amyotrophic lateral sclerosis. Cortex. 2018;101:163-171. 10.1016/j.cortex.2018.01.004. Epub 2018 Jan 31 PMID: 29477906.</Citation></Reference><Reference><Citation>McMackin R, Dukic S, Costello E, et al. Cognitive network hyperactivation and motor cortex decline correlate with ALS prognosis. Neurobiol Aging. 2021;104:57-70.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>